Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Global Generic Drugs Business Analysis Report 2023-2030: Small-molecule Generic Drugs Account for a Lion's Share, Biosimilars Exhibit Fastest Growth

      Research and Markets Logo

      News provided by

      Research and Markets

      Oct 23, 2023, 14:45 ET

      Share this article

      Share this article


      DUBLIN, Oct. 23, 2023 /PRNewswire/ -- The "Generic Drugs - Global Strategic Business Report" report has been added to  ResearchAndMarkets.com's offering.


      Global Generic Drugs Market to Reach $671.5 Billion by 2030

      The global market for Generic Drugs estimated at US$403.9 Billion in the year 2022, is projected to reach a revised size of US$671.5 Billion by 2030, growing at a CAGR of 6.6% over the analysis period 2022-2030.

      Small-Molecule Generics, one of the segments analyzed in the report, is projected to record 4.8% CAGR and reach US$538.8 Billion by the end of the analysis period. Growth in the Biosimilars segment is estimated at 19.1% CAGR for the next 8-year period.

      The U.S. Market is Estimated at $122.8 Billion, While China is Forecast to Grow at 8.2% CAGR

      The Generic Drugs market in the U.S. is estimated at US$122.8 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$126.8 Billion by the year 2030 trailing a CAGR of 8.2% over the analysis period 2022 to 2030.

      Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.8% and 5.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 5.5% CAGR.

      What`s New?

      • Special discussions on the global economic climate and market sentiment
      • Coverage on global competitiveness and key competitor percentage market shares
      • Market presence analysis across multiple geographies - Strong/Active/Niche/Trivial
      • Online interactive peer-to-peer collaborative bespoke updates
      • Access to digital archives and trademarked research platform
      • Complimentary updates for one year
      • Access to curated YouTube video transcripts of market sentiments shared by CEOs, domain experts and market influencers via interviews, podcasts, press statements and event keynotes

      MARKET OVERVIEW

      • Impact of Covid-19 and Global Economic Update
      • COVID-19 Impact on Global Pharmaceutical Supply Chain and Generic Drugs Market
      • Demand for Generic Pain Killers Rises
      • A Prelude to Generic Drugs
      • Generic Drugs Market Set for a Rapid Growth
      • North America and Europe Dominate, Asia-Pacific to Exhibit the Fastest Growth
      • India- A Significant Market
      • Small-molecule Generic Drugs Account for a Lion's Share, Biosimilars Exhibit Fastest Growth
      • Exciting Times for Biosimilars
      • Competition
      • Generic Drugs - Global Key Competitors Percentage Market Share in 2023 (E)
      • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2023 (E)
      • Market Opportunities
      • Strategies to Sustain Success
      • The Future of Generics & Biosimilars Look Bright amid Persistent Barriers
      • Market Challenges
      • Factors Affecting Prices & Accessibility
      • Recent Market Activity
      • BRANDS

      MARKET TRENDS & DRIVERS

      • Generic Drugs Enjoy Adrenaline Rush with Regulatory & Scientific Support
      • R&D & Innovation Push
      • Efforts to Eliminate Barriers to Generics Development
      • Regulatory & Scientific Collaboration as Key
      • FDA's Generic Drug User Free Program
      • Policy Support to Generic Drugs: Clearing Road to Affordable Access to Quality Medicines
      • Savings in Billions
      • Taking GDUFA to Next Level
      • Pushing Competition through ANDAs
      • Major Push to COVID-19 Drugs
      • Patent Expiries Set to Widen the Addressable Market for Generic Drugs
      • Patent Expiries of Select Drugs in 2020
      • Patent Expiries of Select Drugs in 2021
      • Patent Expiries of Select Drugs in 2022
      • Patent Expiries of Select Drugs in 2023
      • Patent Expiry of Select Major Drugs in the US: 2020-2023
      • Robust Demand for Pharmaceutical Drugs Drives Demand for Generic Drugs
      • Cost Containment Measures Put Focus on Generics
      • Small Molecule Generics Represent the Dominant Segment
      • Specialty Generic Drugs Gain Popularity
      • Specialty Generics - The Way to Success Amid Challenges
      • Factors that can Provide Competitive Edge
      • Increasing Demand for Biosimilars, Driven by Patent Expiry of Major Biopharmaceutical Drugs
      • Patent Expiries of Major Biopharmaceutical Drugs in the US and Europe in the Recent Past
      • Progressive Regulatory Framework Accelerates Product Approvals & Subsequently Market Revenues
      • Specific Guidelines for Biosimilars in Various Countries with Year of Publication
      • Biosimilars Regulatory Agencies in Select Regional Markets
      • Biosimilar Approvals in the US (as of 2023)
      • Biosimilar Approvals in Europe (as of 2023)
      • Rising Healthcare Costs Drive Demand for Generic Drugs
      • World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
      • Aging Population to Propel the Demand for Generic Drugs
      • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
      • Significant Increase in Number of Patients Suffering from Chronic Diseases Fuel Demand for Generic Medicines
      • Global Cost of Chronic Diseases (In US$ Billion) for the Years 2018 and 2030
      • Fatalities by Heart Conditions - Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
      • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
      • Number of New Cancer Cases and Deaths (in Million) by Region for 2018
      • US Regulators Struggle to Keep Up with the Global Market
      • Increased Dependency on Non-US Manufacturers
      • Patient Trust and Traceability
      • Drug Supply Shortage Risks
      • Fixing a Broken System
      • Hospitals Teaming Up to Develop Own Generic Drugs to Combat Shortages and High Prices
      • Use of Artificial Intelligence and Machine Learning in Pharmaceutical Manufacturing Witnesses a Surge

      FOCUS ON SELECT PLAYERS (Total 255 Featured)

      • Abbott Laboratories
      • Apotex Inc.
      • ASKA Pharmaceutical Co., Ltd.
      • Aspen Pharmacare Holdings Limited
      • AstraZeneca Plc
      • Baxter International Inc.
      • Dr. Reddy's Laboratories Limited`
      • Eli Lilly and Company
      • Endo International plc
      • F. Hoffmann-La Roche AG
      • Fresenius Kabi AG
      • GSK plc
      • H. Lundbeck A/S
      • Incepta Pharmaceuticals Ltd.
      • Lupin Ltd.
      • Novo Nordisk A/S
      • Sandoz International GmbH
      • Sanofi-Aventis U.S. LLC
      • STADA Arzneimittel AG
      • Sun Pharmaceutical Industries Limited
      • Teva Pharmaceutical Industries Ltd.
      • Viatris Inc.

      For more information about this report visit https://www.researchandmarkets.com/r/uhwdsn

      About ResearchAndMarkets.com
      ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

      Media Contact:

      Research and Markets
      Laura Wood, Senior Manager
      [email protected]
       
      For E.S.T Office Hours Call +1-917-300-0470
      For U.S./CAN Toll Free Call +1-800-526-8630
      For GMT Office Hours Call +353-1-416-8900
       
      U.S. Fax: 646-607-1907
      Fax (outside U.S.): +353-1-481-1716

      Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

      SOURCE Research and Markets

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.